Glucagon-like Peptide-1 Receptor Agonists Prescribing Patterns in Youth with Type 2 Diabetes

被引:0
|
作者
Bensignor, Megan [1 ]
Kelly, Aaron [1 ]
Wolfe, Jack [2 ]
Rudser, Kyle [2 ]
Arslanian, Silva [3 ]
机构
[1] Univ Minnesota, Ctr Pediat Obes Med, Minneapolis, MN USA
[2] Univ Minnesota, Biostat Design & Anal Ctr, Minneapolis, MN USA
[3] UPMC Childrens Hosp, Ctr Pediat Res Obes & Metab, Pittsburgh, PA USA
来源
HORMONE RESEARCH IN PAEDIATRICS | 2022年 / 95卷 / SUPPL 1期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
4849
引用
收藏
页码:81 / 82
页数:2
相关论文
共 50 条
  • [1] Glucagon-like peptide-1 receptor agonist prescribing patterns in adolescents with type 2 diabetes
    Bensignor, Megan O.
    Wolf, Jack M.
    Rudser, Kyle D.
    Kelly, Aaron S.
    Arslanian, Silva
    DIABETES OBESITY & METABOLISM, 2022, 24 (07): : 1380 - 1384
  • [2] Treatment of type 2 diabetes with glucagon-like peptide-1 receptor agonists
    Hansen, K. B.
    Knop, F. K.
    Holst, J. J.
    Vilsboll, T.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2009, 63 (08) : 1154 - 1160
  • [3] It Is Time to Consider Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes in Youth
    Oberle, Megan M.
    Kelly, Aaron S.
    FRONTIERS IN ENDOCRINOLOGY, 2019, 10
  • [4] The Role of Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes in Asia
    Ju-Ming Lu
    Advances in Therapy, 2019, 36 : 798 - 805
  • [5] The Role of Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes in Asia
    Lu, Ju-Ming
    ADVANCES IN THERAPY, 2019, 36 (04) : 798 - 805
  • [6] Effectiveness of glucagon-like peptide-1 agonists in type 2 diabetes
    Pavlicek, Vojtech
    DIABETOLOGIE, 2023, 19 (03): : 359 - 360
  • [7] Glucagon-like peptide-1 agonists in the treatment of type 2 diabetes
    Edwards, C. M. B.
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2013, 74 (04) : 198 - 201
  • [8] Glucagon-like peptide-1 therapy for youth with type 2 diabetes
    Cho, Young Min
    JOURNAL OF DIABETES INVESTIGATION, 2023, 14 (03) : 362 - 363
  • [9] Glucagon-Like Peptide-1 Receptor Agonists
    Edelman, Steven V.
    JOURNAL OF FAMILY PRACTICE, 2017, 66 (10): : S12 - S16
  • [10] Efficacy and safety of high-dose glucagon-like peptide-1, glucagon-like peptide-1/glucose-dependent insulinotropic peptide, and glucagon-like peptide-1/glucagon receptor agonists in type 2 diabetes
    De Block, Christophe E. M.
    Dirinck, Eveline
    Verhaegen, Ann
    Van Gaal, Luc F.
    DIABETES OBESITY & METABOLISM, 2022, 24 (05): : 788 - 805